Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.
| Analyst | Firm | Questions · challengingPercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| A.J. Rice | UBS | 7 questions · 29% challenging |
| Andrew Mok | Barclays | 7 questions · 14% challenging |
| Steve Baxter | Wells Fargo | 7 questions · 29% challenging |
| Justin Lake | Wolfe Research | 7 questions · 14% challenging |
| Lance Wilkes | Bernstein | 7 questions · 0% challenging |
| Josh Raskin | Nephron Research | 6 questions · 33% challenging |
| Sarah James | Cantor Fitzgerald | 6 questions · 17% challenging |
| Ann Hynes | Mizuho Securities | 6 questions · 17% challenging |
| John Stansel | JPMorgan | 5 questions · 0% challenging |
| Kevin Fischbeck | Bank of America | 5 questions · 40% challenging |
| Firm | Analysts | Questions · challengingPercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Bank of America | 3 analysts | 7 questions · 29% challenging |
| Barclays | 1 analyst | 7 questions · 14% challenging |
| Bernstein | 1 analyst | 7 questions · 0% challenging |
| UBS | 1 analyst | 7 questions · 29% challenging |
| Wells Fargo | 1 analyst | 7 questions · 29% challenging |
| Wolfe Research | 1 analyst | 7 questions · 14% challenging |
| Cantor Fitzgerald | 1 analyst | 6 questions · 17% challenging |
| Mizuho Securities | 1 analyst | 6 questions · 17% challenging |
No 8-K events recorded for this window.
Centene delivered a dramatically improved Q1 with adjusted EPS of $3.37, up 20% year-over-year, and raised full-year guidance to greater than $3.40 from the prior $3.00, a 13% increase. Consolidated HBR improved sharply to 87.3%, and the Medicare segment doubled its outperformance while Medicaid HBR continued to improve at 93.1%. The March Wakely report validated marketplace dynamics and ABA trend stabilization provided a proof point, though marketplace silver tier members showed higher acuity than expected and Medicaid work requirements implementation approached.
Margin | Regulation Policy | Pricing | Subscriber Growth | Cost Pressure | Competitive Dynamics | Guidance Reliability | Demand | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 4 | 5 | 1 | 5 | 2 | 4 | 2 | |
| 2025Q1 | 7 | 7 | 3 | 5 | 4 | 1 | 2 | |
| 2025Q2 | 5 | 5 | 2 | 2 | 3 | 2 | 2 | 1 |
| 2025Q3 | 5 | 3 | 4 | 2 | 1 | 4 | 1 | |
| 2025Q4 | 5 | 3 | 4 | 3 | 3 | 3 | 1 | |
| 2026Q1 | 4 | 4 | 5 | 1 | 4 | 2 | 3 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Margin | 4 | 7 | 5 | 5 | 5 | 4 |
| Regulation Policy | 5 | 7 | 5 | 3 | 3 | 4 |
| Pricing | 1 | 3 | 2 | 4 | 4 | 5 |
| Subscriber Growth | 5 | 5 | 2 | 2 | 3 | 1 |
| Cost Pressure | 4 | 3 | 1 | 3 | 4 | |
| Competitive Dynamics | 2 | 2 | 4 | 3 | 2 | |
| Guidance Reliability | 4 | 1 | 2 | 1 | 1 | 3 |
| Demand | 2 | 2 | 1 |
Calendar quarter Q1 2026Earnings call Apr 28, 2026
FY2026 Q1 in brief
Centene delivered a dramatically improved Q1 with adjusted EPS of $3.37, up 20% year-over-year, and raised full-year guidance to greater than $3.40 from the prior $3.00, a 13% increase.
Newest quarter FY2026 Q2 is part of Pro · see what Pro adds →
Sources. Tellvest earnings-call sentiment score for Centene Corporation (CNC), FY2026 Q1: 9/10. Scores: Centene Corporation’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: CNC daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
GAAP revenue YoY +7.13% → base 6. The base score is anchored to the GAAP revenue YoY band before transcript, EPS, and guidance adjustments.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $40.80B | +3.4% | $0.56 | +569.1% | 9.1% | 0.4% | 0.7% | $-741M |
| FY2025 Q1 | $46.62B | +15.4% | $2.63 | +21.8% | 11.2% | 3.3% | 2.8% | $1.38B |
| FY2025 Q2 | $48.74B | +22.4% | $-0.51 | -123.6% | 6.0% | -0.9% | -0.5% | $1.58B |
| FY2025 Q3 | $49.69B | +18.2% | $-13.50 | -1092.6% | 16.4% | -14.0% | -13.3% | $1.15B |
| FY2025 Q4 | $49.73B | +21.9% | $-2.24 | -500.0% | 15.2% | -3.5% | -2.2% | $224M |
| FY2026 Q1Selected | $49.94B | +7.1% | $3.11 | +18.3% | 21.9% | 3.7% | 3.1% | $3.40B |
| FY2026 Q2 | $53.58B | +9.9% | $2.19 | +529.4% | 8.6% | 2.2% | 2.0% | $4.18B |
Management’s own words, often on a non-GAAP, constant-currency, or adjusted basis — so these can differ from the GAAP figures above (e.g. constant-currency revenue growth excludes currency swings).
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
CNC Centene Corporation | 9 | +7.1% | |
| CI Cigna | 8 | +4.6% | |
| CVS CVS Health | 9 | +6.2% | |
| ELV Elevance Health | 7 | +2.6% | |
| HUM Humana | 7 | +23.5% | |
| UNH UnitedHealth Group Incorporated | 7 | +2.0% |